Unknown

Dataset Information

High-throughput drug screen identifies chelerythrine as a selective inducer of death in a TSC2-null setting.


ABSTRACT:

Unlabelled

Tuberous sclerosis complex (TSC) is an autosomal dominant syndrome associated with tumors of the brain, heart, kidney, and lung. The TSC protein complex inhibits the mammalian or mechanistic target of rapamycin complex 1 (mTORC1). Inhibitors of mTORC1, including rapamycin, induce a cytostatic response in TSC tumors, resulting in temporary disease stabilization and prompt regrowth when treatment is stopped. The lack of TSC-specific cytotoxic therapies represents an important unmet clinical need. Using a high-throughput chemical screen in TSC2-deficient, patient-derived cells, we identified a series of molecules antagonized by rapamycin and therefore selective for cells with mTORC1 hyperactivity. In particular, the cell-permeable alkaloid chelerythrine induced reactive oxy

SUBMITTER: Medvetz D 

PROVIDER: S-EPMC4312508 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature